Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

A

Membership required to view content.
issued Friday by the Congressional Research Service (CRS) provides a broad overview of the development of the hemp industry, specifically floral hemp and its associated extracts like CBD. 

The report highlights the role of the FDA in the emerging hemp industry, and its failure to create a regulatory pathway for CBD.  It noted that after years of review by a high-level internal working group, the FDA announced in January it would work with Congress to create a new regulatory pathway for CBD. 

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

11.21.2024

Domestic US biodiesel blending helps lift October RFS RIN production

Domestic US biodiesel blending helps lift October RFS RIN production

US domestic biodiesel blending of 147.5 million gallons in October produced a monthly high of 221.2 million renewable identification number (RIN) credits for January-October. This was 11.5% above September...

11.21.2024

CWG trades lower as broader animal fats markets hold steady

CWG trades lower as broader animal fats markets hold steady

The US animal fats and oils markets held steady on Thursday November 21, with limited trading as attention shifted toward broader macroeconomic factors and...

11.21.2024

October commercial cattle, hog production above 2023

October commercial cattle, hog production above 2023

US animal protein prices were steady on Thursday November 21. Limited trade was reported from market sources due to the proximity of the extended Thanksgiving holiday weekend in the...

Latest Tweets